Protara Therapeutics, Inc. (TARA) Ownership

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$5.43
Day's range
$5.84

Protara Therapeutics Inc Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
JANUS HENDERSON GROUP PLC 05/18/2026 5.21 M $27.15 M   1.27% 12.16%
BLACKROCK, INC. 05/13/2026 3.39 M $17.69 M   40.94% 7.93%
VELAN CAPITAL INVESTMENT MANAGEMENT LP 05/15/2026 2.83 M $14.77 M   0.00% 6.62%
MILLENNIUM MANAGEMENT LLC 05/15/2026 2.83 M $14.75 M   275.84% 6.61%
BLACKSTONE INC. 05/15/2026 2.27 M $11.80 M   18.63% 5.29%
05/15/2026 2.12 M $11.04 M   100.00% 4.95%
SIO CAPITAL MANAGEMENT, LLC 05/14/2026 1.97 M $10.26 M   14.83% 4.60%
ACORN CAPITAL ADVISORS, LLC 05/15/2026 1.75 M $9.13 M   0.00% 4.09%
INTEGRAL HEALTH ASSET MANAGEMENT, LLC 05/15/2026 1.75 M $9.12 M   -22.22% 4.09%
AIGH CAPITAL MANAGEMENT LLC 04/30/2026 1.62 M $8.45 M   100.00% 3.79%
UBS GROUP AG 05/05/2026 1.40 M $7.31 M   15.37% 3.27%
5AM VENTURE MANAGEMENT, LLC 05/15/2026 1.37 M $7.14 M   0.00% 3.20%
GEODE CAPITAL MANAGEMENT, LLC 05/15/2026 1.18 M $6.13 M   44.05% 2.75%
POINT72 ASSET MANAGEMENT, L.P. 05/15/2026 1.15 M $6.01 M   4,001.16% 2.69%
CITADEL ADVISORS LLC 05/15/2026 1.07 M $5.57 M   18.53% 2.49%
PATIENT SQUARE CAPITAL LP 05/15/2026 1.03 M $5.37 M   100.00% 2.41%
STATE STREET CORP 05/15/2026 1.01 M $5.24 M   76.07% 2.35%
BAKER BROS. ADVISORS LP 05/15/2026 971.61 K $5.06 M   0.00% 2.27%
ADAR1 CAPITAL MANAGEMENT, LLC 05/18/2026 940.51 K $4.90 M   -17.27% 2.20%
BANK OF AMERICA CORP /DE/ 05/18/2026 925.92 K $4.82 M   86.71% 2.16%
J. GOLDMAN & CO LP 05/15/2026 856.25 K $4.46 M   100.00% 2.00%
CATALIO CAPITAL MANAGEMENT, LP 05/15/2026 580.02 K $3.02 M   -59.89% 1.35%
ASSENAGON ASSET MANAGEMENT S.A. 04/20/2026 567.62 K $2.96 M   84.09% 1.33%
MORGAN STANLEY 05/15/2026 556.97 K $2.90 M   217.67% 1.30%
DIMENSIONAL FUND ADVISORS LP 05/07/2026 531.27 K $2.77 M   133.88% 1.24%
BURKEHILL GLOBAL MANAGEMENT, LP 05/15/2026 450.00 K $2.34 M   0.00% 1.05%
WALLEYE CAPITAL LLC 05/13/2026 443.40 K $2.31 M   203.96% 1.04%
05/08/2026 412.60 K $2.15 M   100.00% 0.96%
GOLDMAN SACHS GROUP INC 05/15/2026 397.98 K $2.07 M   526.82% 0.93%
NORTHERN TRUST CORP 05/14/2026 374.85 K $1.95 M   55.70% 0.88%
ALYESKA INVESTMENT GROUP, L.P. 05/15/2026 350.00 K $1.82 M   0.00% 0.82%
VANGUARD FIDUCIARY TRUST CO 05/08/2026 308.84 K $1.61 M   100.00% 0.72%
OPPENHEIMER & CO INC 04/24/2026 181.57 K $945.95 K   -18.86% 0.42%
QUBE RESEARCH & TECHNOLOGIES LTD 05/15/2026 177.00 K $922.19 K   54.82% 0.41%
CIBC WORLD MARKET INC. 05/14/2026 175.50 K $914.33 K   -23.33% 0.41%
CITADEL ADVISORS LLC 05/15/2026 149.90 K $780.98 K   408.14% 0.35%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 05/15/2026 147.89 K $770.50 K   44.28% 0.35%
BANK OF NEW YORK MELLON CORP 05/05/2026 129.67 K $675.58 K   38.65% 0.30%
RENAISSANCE TECHNOLOGIES LLC 05/14/2026 125.70 K $654.90 K   -52.89% 0.29%
SUPERSTRING CAPITAL MANAGEMENT LP 05/14/2026 121.46 K $632.79 K   -66.26% 0.28%
PRUDENTIAL FINANCIAL INC 05/13/2026 119.53 K $622.75 K   100.00% 0.28%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 05/15/2026 116.63 K $607.62 K   9.15% 0.27%
EXODUSPOINT CAPITAL MANAGEMENT, LP 05/14/2026 116.31 K $605.95 K   100.00% 0.27%
AMERICAN CENTURY COMPANIES INC 05/15/2026 92.97 K $484.37 K   44.91% 0.22%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 05/15/2026 70.33 K $366.42 K   56.88% 0.16%
AQR CAPITAL MANAGEMENT LLC 05/15/2026 66.81 K $348.05 K   355.04% 0.16%
JUMP FINANCIAL, LLC 05/14/2026 66.78 K $347.92 K   100.00% 0.16%
NUVEEN, LLC 04/30/2026 63.86 K $332.71 K   -26.17% 0.15%
TRUIST FINANCIAL CORP 04/27/2026 60.00 K $312.60 K   50.00% 0.14%
XTX TOPCO LTD 05/15/2026 58.80 K $306.35 K   -49.03% 0.14%

Protara Therapeutics Inc institutional Ownership - FAQ's

During the previous two years, 144 institutional investors and hedge funds held shares of Protara Therapeutics Inc. The most heavily invested institutionals were:

Walleye Capital LLC: 505,432

OPPENHEIMER & CO INC: 238,362

Bank of New York Mellon Corp: 137,689

Fisher Asset Management, LLC: 99,566

TRUIST FINANCIAL CORP: 60,000

Assenagon Asset Management S.A.: 59,954

106.36% of Protara Therapeutics Inc stock is owned by institutional investors.

Institutional investors have bought a total of 46.50 M shares in the last 24 months. This purchase volume represents approximately $267.36 M in transactions.